Doctor vs. Doctora: Gender Equality in Medical Research – The Case of Ana Checa
Spanish researchers have identified a promising new class of drugs—led by Ruvid (a dual-acting glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist)—that may slow the dual damage to the heart and ... Read More